Two Sigma Advisers
MCRB icon

Two Sigma Advisers’s Seres Therapeutics MCRB Stock Holding History

Two Sigma Advisers’s Portfolio MCRB Stock Details MCRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-985
Closed -$110K – 2680
2022
Q4 		$110K Sell
985
-4,715
-83% -$632K ﹤0.01% 2280
2022
Q3 		$732K Sell
5,700
-8,335
-59% -$854K ﹤0.01% 1682
2022
Q2 		$963K Sell
14,035
-100
-0.7% -$8.62K ﹤0.01% 1615
2022
Q1 		$2.01M Buy
14,135
+1,840
+15% +$283K 0.01% 1249
2021
Q4 		$2.05M Sell
12,295
-14,550
-54% -$2.31M 0.01% 1193
2021
Q3 		$3.74M Buy
26,845
+25,155
+1,488% +$4.92M 0.01% 930
2021
Q2 		$806K Sell
1,690
-4,270
-72% -$1.8M ﹤0.01% 1730
2021
Q1 		$2.45M Buy
5,960
+3,645
+157% +$1.68M 0.01% 1171
2020
Q4 		$1.13M Buy
2,315
+635
+38% +$372K ﹤0.01% 1507
2020
Q3 		$951K Sell
1,680
-4,165
-71% -$1.39M ﹤0.01% 1521
2020
Q2 		$556K Buy
5,845
+1,380
+31% +$121K ﹤0.01% 1849
2020
Q1 		$319K Buy
4,465
+585
+15% +$39.2K ﹤0.01% 1988
2019
Q4 		$268K Buy
3,880
+730
+23% +$54.1K ﹤0.01% 2098
2019
Q3 		$253K Buy
3,150
+810
+35% +$53.5K ﹤0.01% 1978
2019
Q2 		$151K Buy
2,340
+1,180
+102% +$112K ﹤0.01% 2170
2019
Q1 		$159K Buy
1,160
+300
+35% +$36.6K ﹤0.01% 2147
2018
Q4 		$78K Sell
860
-80
-9% -$11.2K ﹤0.01% 2240
2018
Q3 		$143K Sell
940
-125
-12% -$20.2K ﹤0.01% 2123
2018
Q2 		$183K Buy
1,065
+190
+22% +$31K ﹤0.01% 2214
2018
Q1 		$128K Sell
875
-900
-51% -$173K ﹤0.01% 2202
2017
Q4 		$360K Buy
1,775
+1,075
+154% +$221K ﹤0.01% 1884
2017
Q3 		$225K Buy
700
+190
+37% +$51.9K ﹤0.01% 2022
2017
Q2 		$115K Hold
510
– – ﹤0.01% 2171
2017
Q1 		$115K Buy
510
+10
+2% +$2.03K ﹤0.01% 2266
2016
Q4 		$99K Buy
+500
New +$109K ﹤0.01% 2267

Other funds holding MCRB

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Two Sigma Advisers's MCRB Position: Q1 2023 in Review

Two Sigma Advisers sold out of Seres Therapeutics (MCRB) in Q1 2023, closing a stake of 985 shares — an estimated $110K sold.

Two Sigma Advisers first reported a position in MCRB in Q4 2016 and held it in 25 quarters. The position peaked at $3.74M in Q3 2021. 123 funds tracked by Wall St. Rank hold MCRB as of Q1 2023.

  • Two Sigma Advisers reported no remaining Seres Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Two Sigma Advisers sold 985 Seres Therapeutics shares in Q1 2023, an estimated $110K.
  • Two Sigma Advisers first reported a position in Seres Therapeutics in Q4 2016 and held it in 25 quarters.
  • Two Sigma Advisers's Seres Therapeutics position peaked at $3.74M in Q3 2021.
  • 123 funds tracked by Wall St. Rank held Seres Therapeutics as of Q1 2023.

Based on Two Sigma Advisers's 13F filing for Q1 2023, filed 15 May 2023.